The short answer
Choose how you want to read this
The whole article, with every detail and caution.
Being told you have a rare cancer changes the practical problem you are solving. With a common cancer, the challenge is usually choosing among established options. With a rare one, the first challenge is often making sure the diagnosis is right. The second is finding someone who has treated more than one or two cases. Neither happens automatically.
What counts as rare, and why it makes everything harder
The National Cancer Institute defines a rare cancer as one that affects fewer than 40,000 people per year in the United States. It also notes that rare cancers together account for a little over a quarter of all cancers. Childhood cancer is uncommon by nature, so all pediatric cancers fall into this category. Rare cancers are rare one by one, but common as a group.
NCI lists the problems plainly. Patients may face delays in learning the type of cancer. They may have trouble finding a specialist. Doctors may disagree about treatment. And people may need to travel far for care. Doctors may have had limited training in a given rare cancer, may struggle to reach an expert, and may have little reliable information on prognosis to share. Researchers have too few tumor samples, few lab models and too few patients for conventional trials.
Start with the pathology
For a rare cancer, everything after the diagnosis follows from what the tumor is called. That includes surgery, drugs, radiation and trial eligibility.
Ask for a second opinion on the pathology, ideally from a center that sees your tumor type. NCI says patients or their doctors may want one. The new pathologist needs your slides or paraffin block, which come from the hospital where the biopsy or surgery was done.
NCI also explains that some molecular tests (also called biomarker tests) are part of the first pathology work-up for certain cancer types. Ask your team which tests apply to you. Ask for the full pathology report too. You can ask to talk it over with the pathologist. Many reports appear in the patient portal when your doctor gets them.
Do this before treatment starts if you can. Cancer staging explains how stage drives treatment decisions.
Where the expertise actually sits
NCI-Designated Cancer Centers. The NCI Cancer Centers Program was created under the National Cancer Act of 1971. NCI recognizes centers that meet rigorous research standards. The three types are Basic Laboratory, Clinical and Comprehensive Cancer Centers. NCI's Find a Cancer Center page lists them with contact details for referrals. Designation does not tell you how many cases of your tumor a center sees. You still have to ask.
Second opinions. NCI says second opinions are very common and that doctors are usually not offended by the request.
Registries and natural history studies. NCI started the MyPART network (My Pediatric and Adult Rare Tumor network) to make it easier to find treatments for rare cancers. Ask your team whether a study or registry is open to you.
Trials and rare cancers
NCI notes that rare cancers often have too few patients for conventional studies. That makes it worth asking early whether a trial fits you. See what clinical trials are for how they work.
Practical steps
- Ask for expert pathology review at a center that specializes in your tumor type, before treatment if possible.
- Ask whether molecular (biomarker) testing applies to you. Ask for the report.
- Get complete copies of everything: pathology, imaging on disc, operative notes. You will send them repeatedly.
- Search the NCI directory for designated centers. Then call and ask how many cases of your specific tumor they see per year.
- Ask about registries and natural history studies, including MyPART.
- Bring questions to ask before treatment begins to each consultation.
- If the cancer has spread, read metastatic cancer so you can follow what is being proposed.
All of this takes energy that you may not have. If travel or time off work makes it hard, say so to your team and ask what they can arrange for you.
Sources
- National Cancer Institute — About Rare Cancers (MyPART)
- National Cancer Institute — Pathology Reports Fact Sheet
- National Cancer Institute — Finding Cancer Care
- National Cancer Institute — Participate in MyPART (listed, not opened in this check)
- National Cancer Institute — NCI Cancer Centers Program
Common questions
What counts as a rare cancer?
NCI defines a rare cancer as one that affects fewer than 40,000 people per year in the United States. Rare cancers together account for just over a quarter of all cancers, and because childhood cancer is uncommon by nature, all pediatric cancers fall into this group. Rare cancers are rare one by one, but common as a group.
Why should I get the pathology looked at again?
Because treatment and trial eligibility follow from what the tumor is called. NCI says patients or their doctors may want a second opinion from another pathologist. The new pathologist needs the slides or paraffin block from the hospital where your biopsy or surgery was done, so no procedure is repeated.
Is going to an NCI-Designated Cancer Center enough?
It is a useful starting point, not a guarantee. NCI designation recognizes centers that meet rigorous research standards, and NCI's Find a Cancer Center page lists them. The designation does not say how many cases of your tumor a center sees, so call and ask.
Is a clinical trial a last resort for a rare cancer?
Not necessarily. NCI notes that rare cancers have too few patients for conventional studies, so research is harder. That makes it worth asking your team early whether any trial fits you. See what clinical trials are for how they work.
This is a lot of work. What if I cannot do all of it?
Say that out loud to your team. Travel or time off work can make parts of it hard. Ask which steps they can handle for you, such as sending slides and records. NCI also notes that second opinions are very common, and that doctors are usually not offended by the request.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
A practical way to use what you just read.
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-11 what this meansLast updated: 2026-10-02Next planned review: 2027-07-26
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
General education. Low-risk educational or organizational content. Medical facts are cited to authoritative sources.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Knowledge check
0 of 2 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.